InsidersTradesSigma
基于 2 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。
Explore the detailed record of transactions filed by Golumbeski George, 董事. Officer active across 3 companies, notably Shattuck Labs, Inc.. Cumulatively, 4 disclosures have been logged. Split: 3 buys · 0 sell. Total volume traded: €424k. Activity tracked since 21 April 2022. The latest transaction was filed on 3 June 2026 (Attribution). Regulator: SEC (Form 4). The full history is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4 条申报中的 4 条
George Golumbeski is a Director at Shattuck Labs, Inc. and Sage Therapeutics, Inc. In these roles, he participates in the governance of the companies and strategic decision-making. Golumbeski brings expertise in biotechnology and drug development, contributing to innovation and performance at the companies.